RHY 1.45% 7.0¢ rhythm biosciences limited

From what I can gather COLVERA is insufficiently sensitive for...

  1. 30 Posts.
    From what I can gather COLVERA is insufficiently sensitive for use as a screening test for bowel cancer, it is useful in people who are known to have had the cancer to test for recurrence.

    In contrast, as you know, COLOSTAT is designed as a low cost screening tool for the early and accurate detection of colorectal cancers.

    Hopefully it proves to be cheap enough and accurate enough to find an enormous worldwide market!
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.001(1.45%)
Mkt cap ! $17.40M
Open High Low Value Volume
6.4¢ 7.0¢ 6.3¢ $44.97K 688.7K

Buyers (Bids)

No. Vol. Price($)
1 266418 6.5¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 86753 4
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.